ACTIVE PHARMA AS: årsregnskap 2023 vs 2022
Shrank 39% on revenue, stronger earnings, cash halved-plus
approved 2024-07-18; registry 2024-07-20; journal 2024 654239
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ACTIVE PHARMA AS. Revenue 670.8k NOK → 412.3k NOK (-38.5%). Net result +66.0k NOK → +212.0k NOK. Equity -177.6k NOK → 34.4k NOK.
On the constructive side: operating result improved; net result improved; equity strengthened. Pressures included: revenue fell; cash fell.
Also worth watching: headcount (årsverk) changed. All figures are taken from the published annual accounts for ACTIVE PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result +29.5k NOK → +213.7k NOK (op. margin 4.4% → 51.8%). Calculated
-
↑
Net result improved
Net result +66.0k NOK → +212.0k NOK (net margin 9.8% → 51.4%). Calculated
-
↑
Equity strengthened
Book equity -177.6k NOK → 34.4k NOK (equity ratio -144.7% → 33.2%). Calculated
-
↑
Payroll decreased
Salary cost 420.1k NOK → 173.4k NOK (63% → 42% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 670.8k NOK to 412.3k NOK (-38.5% YoY). Calculated
-
↓
Cash fell
Bank deposits 118.9k NOK → 10.5k NOK (-91.2% YoY). Calculated
Things to notice
-
·
Headcount (årsverk) changed
Reported FTEs 1 → 0.5. Reported fact